How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?

被引：10

作者：

Bassetti, Matteo ^{[1
,2
]}

Peghin, Maddalena ^{[1
,2
]}

Carnelutti, Alessia ^{[1
,2
]}

Righi, Elda ^{[1
,2
]}

机构：

[1] Univ Udine, Dept Med, Infect Dis Clin, Udine, Italy

[2] Santa Maria Misericordia Hosp, Udine, Italy

来源：

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 38卷 / 03期

关键词：

hospital-acquired pneumonia; ventilator-acquired pneumonia; carbapenemase-producing Enterobacteriaceae; antibiotic therapy; multidrug-resistant gram negative; VENTILATOR-ASSOCIATED PNEUMONIA; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; RESPIRATORY-TRACT INFECTIONS; HOSPITAL-ACQUIRED PNEUMONIA; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; COLISTIN METHANESULFONATE; RETROSPECTIVE ANALYSIS;

D O I：

10.1055/s-0037-1602656

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) represent a common problem in hospital setting worldwide. Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) are an emergent problem due to the lack of therapeutic options available, leading to significant increases in morbidity and mortality. CRE have frequently been reported both in HAP/VAP, but limited data regarding the optimal treatment strategy in this setting are available. This review focuses on the current epidemiology of CRE, with a specific focus on HAP/VAP. Moreover, we will suggest a possible strategy for the empiric and targeted treatment of HAP and VAP in which the involvement of CRE is suspected or is confirmed.

引用

页码：301 / 310

页数：10

共 50 条

[21] Over-treatment of carbapenemase-producing Enterobacteriaceae
Rihani, Deba S.
Wallace, Mark R.
Sieger, Barry E.
Waite, Robert A.
Fox, Marlena
Brown, Scott A.
Deryke, C. Andrew
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (05) : 325 - 329
[22] First detection of a carbapenemase-producing Enterobacteriaceae in Iceland
Helgason, Kristjan O.
Jelle, Asdis E.
Edvardsson, Vidar
Findlay, Jacqueline
Hopkins, Katie L.
Woodford, Neil
Samuelsen, Orjan
Hardarson, Hordur S.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 6 : 73 - 74
[23] Managing Carbapenemase-producing Enterobacteriaceae In A Transplant Setting
Hill, L.
Dignan, F.
Blagburn, N.
Saif, M.
Tholouli, E.
BONE MARROW TRANSPLANTATION, 2016, 51 : S560 - S560
[24] Strategy for Rapid Detection of Carbapenemase-Producing Enterobacteriaceae
Dortet, Laurent
Brechard, Ludivine
Cuzon, Gaelle
Poirel, Laurent
Nordmann, Patrice
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2441 - 2445
[25] Hazard Ratios and Hazardous Carbapenemase-Producing Enterobacteriaceae
Corona, Alberto
De Santis, Vincenzo
Singer, Mervyn
CRITICAL CARE MEDICINE, 2015, 43 (11) : E536 - E537
[26] Carbapenemase-Producing Enterobacteriaceae in Yunnan Province, China
Zheng Rui
Liu Dehua
Niu Hua
Feng Yue
Xu Yunmin
Li Jianhua
Xia Xueshan
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2016, 69 (06) : 528 - 530
[27] Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review
Kopotsa, Katlego
Sekyere, John Osei
Mbelle, Nontombi Marylucy
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1457 (01) : 61 - 91
[28] Carbapenemase-producing Enterobacteriaceae in animals and methodologies for their detection
Anderson, Rebecca E., V
Boerlin, Patrick
CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2020, 84 (01): : 3 - 17
[29] Carbapenemase-producing Enterobacteriaceae surveillance in Malaysian hospitals
Norazah, A.
Suraya, A.
Farah, B. Nor
Surianti, S.
Rohaidah, H.
Rohana, O.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S102 - S103
[30] How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies
Bilavsky, Efraim
Schwaber, Mitchell J.
Carmeli, Yehuda
CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (04) : 327 - 331

← 1 2 3 4 5 →